Andrew Innes

Jan 31, 2024 | onlinelibrary.wiley.com | Mark Robinson |Philippa May |Andrew Innes |Han Leng Ng

INTRODUCTION Myeloid leukaemia is the most prevalent haematological malignancy in individuals aged over 65, with UK annual incidence rates in this age group of 20 per 100 000 and 7.8 per 100 000 for acute myeloid leukaemia (AML) and chronic myeloid leukaemia (CML) respectively.1 CML comprises two phases; chronic phase (CP), which is the most common phase at diagnosis, and now has a near normal life expectancy for those who respond to therapy,2 and blast phase (BP), characterised by increased...

Apr 4, 2023 | nature.com | Andrew Innes |Jane F. Apperley

Authors and AffiliationsCentre for Haematology, Imperial College London, London, UKFiona Fernando, Andrew J. Innes, Simone Claudiani, Angharad Pryce, Jane F. Apperley & Dragana MilojkovicDepartment of Clinical Haematology, Imperial College Healthcare NHS Trust, London, UKFiona Fernando, Andrew J. Innes, Simone Claudiani, Angharad Pryce, Jane F.